‌

US Patent 9376673 Beta-lactamases with improved properties for therapy

Patent 9376673 was granted and assigned to Synthetic Biologics, Inc. on June, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Synthetic Biologics, Inc.

Current Assignee

Synthetic Biologics, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9376673

Date of Patent

June 28, 2016

Patent Application Number

15019474

Date Filed

February 9, 2016

Patent Primary Examiner

‌

Suzanne M Noakes

Patent abstract

This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract) disorders such as C. difficile infection (CDI).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9376673 Beta-lactamases with improved properties for therapy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API